Context Therapeutics Inc.
Context Therapeutics Inc. (CNTX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cntx · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$6.00
Consensus
$5.25
+207.0% upside
Low
$4.50
Median: $5.25 · Last Close: $1.71
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$5.25
207.0% upside
High Target
$6
250.9%
Low Target
$4.5
163.2%
Current Price
$1.71
as of today
Based on analyst price targets, the CNTX stock price prediction for the next 12 months ranges from $4.5 to $6. The consensus CNTX price forecast of $5.25 implies 207.0% upside from the current price of $1.71.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.62 | ↓ 5.00% |
1-day model range: $1.61–$1.64. Peak: $1.64 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -32.7% |
| 2028 | $1 | -43.7% |
| 2029 | $1 | -48.3% |
| 2030 | $1 | -50.4% |
| 2031 | — | -51.4% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CNTX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-24 | Guggenheim | Maintains | Buy→Buy |
| 2026-03-24 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-24 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-11-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-06 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-10-16 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-08-07 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-08-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-26 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-05-08 | D. Boral Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Context Therapeutics Inc. (CNTX) stock. Of the recent 27 rating actions, 1 were upgrades and 1 were downgrades. 6 analysts currently cover CNTX.
Analyst Recommendation Trends
CNTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 18.4% YoY
Revenue Next Year
$0M
↓ 100.0% YoY
EPS This Year
$-0.39
EPS Next Year
$-0.41
↑ 4.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast CNTX EPS of $-0.39 for the current fiscal year, based on estimates from 7 analysts. The CNTX revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CNTX stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CNTX price target is $5.25 (+207.0% upside), with an analyst consensus of Buy.
The CNTX short-term stock prediction for tomorrow is $1.62 (-5.00%). The CNTX stock price prediction for 2027 estimates an average of $1. The CNTX stock prediction for 2030 projects a range of $1–$1.
Context Therapeutics Inc. trades on NASDAQ under the ticker CNTX. The CNTX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
CNTX forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month CNTX price target is $5.25, with a high forecast of $6.00 and a low of $4.50. The median price target is shown in the chart above when available. This implies +207.0% potential upside from the current price of $1.71.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.